SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : SPIN-OFFS "secret hiding places of stock market profits"

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (342)9/27/1999 11:03:00 AM
From: Stewart Whitman  Read Replies (1) of 1185
 
Paul,

Regarding SNC, I picked up some Ventiv Health WI (NASDAQ:VTIVV) trading at 9 and change. You might want to check it out - pretty good value I believe.

My stats were as follows:

25 million shares
$230 million market cap
$350 million sales
~$1 EPS (more or less)
7% margins

- very good cash flow business (low capex),
- parent is buying back shares,
- good insider ownership
- managers have options, and incentives
- good barriers for entry/exit (cost of switching, specific skill sets)

Historical revenue growth has been spectacular with much through acquisition. Internal revenue growth has been > 20% - though it has stalled this year. I believe they're having some difficulties digesting some acquisitions in Europe.

You can also do some comparisons with Quintiles Transnational (NASDAQ:QTRN). About 40% of its operations is what they call "commercialization" (the other segment is product development - i.e. "research"). On a cash flow basis, the commercialization side is a much better business than the product development side. QTRN trades at a P/S that's about double VTIVV. QTRN is also significantly off its highs of earlier this year.

Regards,
Stew
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext